Unilateral pulmonary edema as a life-threatening complication of ritodrine

Acta Obstetricia et Gynecologica Scandinavica

Volumn 78, Issue 10, 1999, Pages 915-916

  Bax, Arjan ^a   Middeldorp, Anne Mieke ^a   Harinck, Bert ^a   Holleboom, Cas ^b   Van Roosmalen, Jos ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Maternal morbidity; Pulmonary edema; Ritodrine

Indexed keywords

RITODRINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EDEMA; PREMATURE LABOR; PRIORITY JOURNAL; TWIN PREGNANCY;

ADULT; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PULMONARY EDEMA; RITODRINE; SYMPATHOMIMETICS; TOCOLYTIC AGENTS;

EID: 0032734153     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Besinger RE. A systematic review of reverse events documented in the use of currently available treatment of preterm labour. In: Keirse MJNC ed. Research and clinical forums: New perspectives for the effective treatment of preterm labour An international consensus. Wells Medical, Kent 1994; 88-99.
2. Armson BA, Samuels P, Miller F, Verbalis J, Main EK. Evaluation of maternal fluid dynamics during tocolytic therapy with ritodrine hydrochloride and magnesium sulfate. Am J Obstet Gynecol 1992; 167: 758-65.
3. Anonymous. Beta-adrenergic agonists and pulmonary oedema in preterm labour. Br Med J 1994; 308: 260-2.
4. Gabriel R, Harika G, Saniez D, Durot S, Quereux C, Wahl P. Prolonged intraveneus ritodrine therapy: a comparison between multiple and singleton pregnancies. Eur J Obstet Gynecol Reprod Biol 1994; 57: 65-71.
5. Wesselius-de Casparis A, Thiery M, Yo le Sian A et al. Results of double-blind, multicentre study with ritodrine in premature labour. Br Med J 1971; 3: 144-7.
6. Levano KJ, Klein VR, Guzick DS, Young DC, Hankins GDV, Williams ML. Single-centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet 1986; 1: 1293-6.
7. King JF, Grant A, Keirse MJN, Chalmers I. Beta-mitectics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 1988; 95: 211-22.
8. Higby K, Xenakis M-L, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993; 168: 1247-59.
9. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 308-12.
10. Wolff F, Fisher JH. Aspects of the pathofysiology of maternal lung edema during tocolytic therapy. J Perinat Med 1988; 16: 50-1.
11. Holleboom CA, Merkus JM, van Elferen LW, Keirse MJ. Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. Br J Obstet Gynaecol 1996; 103: 695-701.
12. Papatsonis DNM, van Geijn HP, Bleker OP, Lange FM, Ader HJ, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997; 90: 230-4.
13. Childress CH, Katz VL. Nifedipine and its indication in obstetrics and gynecology. Obstet Gynecol 1994; 83: 16-24.
14. Goodwin TM, Valenzuela GJ, Silver H, Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labour. Atosiban Study Group. Obstet Gynecol 1996; 88: 331-6.
15. Graber EA. Dilemmas in the pharmological management of preterm labor. Obstet Gynecol Surv 1989; 44: 512-17.
16. Lockwood CJ, Senyei AE, Dische MR et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325: 669-74.
17. Chien PF, Khan KS, Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol 1997; 104: 436-44.
18. Kagele SF, Charan NB. Unilateral pulmonary edema: an unusual cause. Chest 1992: 102: 1279-80.